As the world’s largest exporter of generic drugs, India imports more than 70 per cent of the necessary ingredients from other countries. This arrangement came to a standstill due to the supply chain disruptions caused by the global pandemic. The turn of events drove India to ramp up production of pharmaceutical ingredients at short notice to meet global demand for drugs.
To improve productivity such that urgent demand can be met, many Indian pharma manufacturing operators are increasingly connecting operating technology (OT) with IT systems to make production as cost-efficient and adaptable as possible. While the convergence of OT and IT systems brings about many benefits, it also creates new avenues for cyberattacks to occur in once-isolated OT environments. A recent Forrester commissioned study revealed that 97 per cent of Indian organizations suffered one or more business-impacting cyberattacks and that 67 per cent of those involved OT systems.
According to a report, India-based pharmaceutical facilities are listed as among the world’s most vulnerable and are very likely to suffer a cyberattack. In the same report, nearly 45 per cent of the devices within Indian pharmaceutical facilities were targeted by cybercriminals in 2019 and this number is steadily growing. Therefore, to prevent future attacks in pharma manufacturing, it is essential to identify security gaps that could impact the integrity of operations.
Some of the gaps that can be leveraged by cybercriminals:
This story is from the October 2020 edition of BioSpectrum Asia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the October 2020 edition of BioSpectrum Asia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Ushering Fourth Industrial Revolution in Telangana
Taking advantage of the 21st edition of BioAsia 2024 at the Hyderabad International Convention Centre (HICC) in Madhapur, the Government of Telangana, a southern state in India, leveraged the confluence of the global platform to spearhead initiatives aimed at propelling the state into the forefront of the Fourth Industrial Revolution (C4IR).
How Indian Biotech Investments are on a Doubling Spree
A latest report by Ankur Capital provides a closer look at the investments made in biotechnology in the last decade in the country.
"AI will be integrally involved in not only the diagnosis of cancer but also in determining the prognosis and best therapeutic option”
South Korea-based Deep Bio, a pioneering artificial intelligence (AI) healthcare firm focused on cancer pathology, is making waves in the industry.
"Because of its specificity and selectivity, ADCS have the potential to reduce adverse side effects and improve patient survival"
Japan-headquartered Daiichi Sankyo, the global healthcare company, launched its subsidiary Daiichi Sankyo Singapore Pte. Ltd. to bridge unmet needs in oncology.
Can Test, Treat, Track Beat Malaria?
Malaria has long been a major public health concern in the Asia Pacific region, particularly in South East Asia (SEA) affecting millions of people.
Engineering CAR T cell sharpshooters
Approved CAR T-cell therapies have shown remarkable results in patients with certain types of blood cancers.
Addressing Challenges in Cell Therapy Manufacturing
Even with significant advancements, there are still anumber of issues with cell therapy manufacturing that need to be resolved as production grows.
"We anticipate India will adopt decentralised models for managing CGTs, ensuring closer proximity between patients and treatment facilities"
Cell and gene therapy (CGT) expert from Germany, Miltenyi Biotec has recently announced its entry into the Indian market to provide researchers, scientists and clinicians easier access to expertise, research, and manufacturing solutions.
Addressing Accessibility and Affordability of CELL & GENE THERAPIES
Cell and gene therapies (CGT) are one of the hottest sectors in the pharmaceutical industry.
Korea designs sweat resistant wearable robot sensor
New electromyography (EMG) sensor technology that allows the long-term stable control of wearable robots and is not affected by the wearer's sweat and dead skin has gained attention recently.